Showing results (191-200 of 232) with videos related to
Sort By:
Pageof 24
Nanomedicine : Nanotechnology, Biology, and Medicine|September 22, 2014
Susceptibility of PTEN-positive metastatic tumors to small interfering RNA targeting the mammalian target of rapamycinHiroyuki Koide, Tomohiro Asai, Hiroki Kato, et al.Frontiers in Genetics|August 17, 2019
Therapeutic Silencing of Centromere Protein X Ameliorates Hyperglycemia in Zebrafish and Mouse Models of Type 2 Diabetes MellitusLiqing Zang, Yasuhito Shimada, Hiroko Nakayama, et al.International Journal of Pharmaceutics|October 12, 2010
PET imaging of brain cancer with positron emitter-labeled liposomesNaoto Oku, Mina Yamashita, Yurie Katayama, et al.International Journal of Pharmaceutics|September 19, 2012
Ability of fibrinogen γ-derived dodecapeptides with different sequences to bind to rat plateletsKoji Tokutomi, Toshiaki Tagawa, Maki Korenaga, et al.International Journal of Pharmaceutics|January 22, 2011
Decoration of fibrinogen γ-chain peptide on adenosine diphosphate-encapsulated liposomes enhances binding of the liposomes to activated plateletsKoji Tokutomi, Toshiaki Tagawa, Maki Korenaga, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|December 30, 2018
Rigorous control of vesicle-forming lipid pKa by fluorine-conjugated bioisosteres for gene-silencing with siRNAAyaka Okamoto, Hiroyuki Koide, Naoki Morita, et al.FEBS Letters|June 5, 2002
Anti-neovascular therapy by liposomal DPP-CNDAC targeted to angiogenic vesselsTomohiro Asai, Kosuke Shimizu, Masami Kondo, et al.Biochemical and Biophysical Research Communications|February 4, 2014
Cell-penetrating peptide-conjugated lipid nanoparticles for siRNA deliveryTomohiro Asai, Takuma Tsuzuku, Shoya Takahashi, et al.International Journal of Pharmaceutics|March 16, 2010
T cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomesHiroyuki Koide, Tomohiro Asai, Kentaro Hatanaka, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|October 25, 2011
Development of anti-HB-EGF immunoliposomes for the treatment of breast cancerKaoru Nishikawa, Tomohiro Asai, Hirokazu Shigematsu, et al.Pageof 24